Respiratory Illness season is right around the corner and experts are urging parents to take action to protect their newborns ...

As we enter cold and flu season, the medical community wants pregnant women to know it's now recommended they receive the RSV ...

Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

Overall, 55.8% of infants were protected by either maternal RSV vaccination, nirsevimab, or both; 14.2% of infants were ...

The effectiveness of the long-acting monoclonal antibody nirsevimab (Beyfortus) against primary care visits for lower ...

According to the CDC, 100,000 older adults a year end up in the hospital, and about 10,000 older adults die from RSV every ...

As the days grow cooler, families across Utah are reminded that respiratory viruses, particularly Respiratory Syncytial Virus ...

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

According to data from Texas Health and Human Services, ER visits for COVID-19, the flu and RSV began to climb at this time ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infantsParis, October 9, ...

RSV is the most harmful respiratory illness for young infants, says Dr. Jeffrey Pernica, a professor in the Department of ...